比亞迪電子(00285.HK)逆市插5% 斥158億人幣購成都無錫手機零件製造業務
比亞迪電子(00285.HK)今日(28日)高開2.2%,初段高見33.85元,但其後掉頭回落,曾倒跌9.3%低見29.8元;現報31.15元,逆市倒跌5.18%,成交762.08萬股,涉資2.38億元。
較早時比亞迪電子宣布,有條件同意以158億元人民幣向捷普電子(JBL.US)附屬捷普電路(新加坡),收購目標公司Juno Newco Target Holdco Singapore的100%股權,後者於成都及無錫從事手機零件製造業務。
港股現升312點或1.7%,報18,269,成交405.23億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.